Volume Buzz: Agilent Technologies Inc. (NYSE:A), Eli Lilly & Co. (NYSE:LLY)

Lakeway, NY -- (SBWIRE) -- 02/22/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

The Agilent Technologies Inc.(NYSE:A) Subsidiary Dako has received approval from US Food and Drug Administration for its newly-launched IQISH technology in the US.

The technology for Dako is designed to speed up the evaluation of cancer cells so that suitable treatment can be determined. Using this technology, it will just take three and a half hours instead of two days for evaluating cancer cells. The speedy evaluation will help doctors in starting treatment at the soonest possible.

Is Agilent Ready To Move back To New highs? Lets’ find Out Here

Agilent Technologies acquired Dako, the Danish cancer diagnostics company for $2.2 billion (on a debt-free basis) last year. Dako provides antibodies, scientific instruments, and software to cancer-related diagnostic labs and works in collaboration with drug companies for developing methods to identify patients likely to benefit from certain therapies.

Dako has collaborated with other pharmaceutical giants like Eli Lilly and Co and Pfizer Inc for developing technologies in the field of companion diagnostics to detect cancer.

Eli Lilly & Co. (NYSE:LLY) announced that Team Solutions and Solutions for Wellness Program resources for individuals living with serious mental illnesses (like bipolar disorder and schizophrenia) have been added to the Substance Abuse and Mental Health Services Administration’s (SAMHSA) National Registry of Evidence –Based Programs and Practices (NREPP).

Will LLY Continue To Hit New highs? Get Special Trend Analysis Here

NREPP is an online registry of evidence-based interventions for the prevention and treatment of mental and substance use disorders.

Team Solutions and Solutions for Wellness were developed by Lilly in collaboration with psychiatric experts to empower people with psychiatric illnesses to make informed decisions.

Studies revealed that the program improves the well-being of people suffering from serious mental illnesses, including improvement in patient Body Mass Index, blood pressure, and knowledge about their illnesses.

Despite these advancements in treatment, individuals suffering from serious mental illness die an average of 25 years younger than the overall population. The higher death rate is attributable to cardiovascular disease and diabetes, caused due to factors such as poor nutrition and lack of exercise.

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.